Shire PLC (SHP) to Issue Dividend of GBX 3.85 on October 20th
Shire PLC (LON:SHP) declared a dividend on Thursday, August 3rd, Upcoming.Co.Uk reports. Shareholders of record on Thursday, September 7th will be paid a dividend of GBX 3.85 ($0.05) per share by the biopharmaceutical company on Friday, October 20th. This represents a dividend yield of 0.1%. The ex-dividend date is Thursday, September 7th. The official announcement can be viewed at this link.
Shares of Shire PLC (LON:SHP) traded up 2.40% on Friday, hitting GBX 3925.50. 1,958,592 shares of the company’s stock traded hands. The company’s market cap is GBX 35.58 billion. Shire PLC has a 1-year low of GBX 3,603.50 and a 1-year high of GBX 5,377.00. The firm’s 50-day moving average price is GBX 3,988.61 and its 200 day moving average price is GBX 4,452.49.
SHP has been the subject of a number of recent analyst reports. Citigroup Inc. reaffirmed a “buy” rating and issued a GBX 6,500 ($84.07) price target on shares of Shire PLC in a research note on Wednesday, May 17th. Deutsche Bank AG reaffirmed a “buy” rating and issued a GBX 6,000 ($77.60) price target on shares of Shire PLC in a research note on Friday, August 4th. HSBC Holdings plc raised Shire PLC to a “hold” rating and set a GBX 4,450 ($57.55) price target for the company in a research note on Thursday, July 6th. Shore Capital reaffirmed a “buy” rating on shares of Shire PLC in a research note on Wednesday, July 19th. Finally, Liberum Capital reaffirmed a “hold” rating and issued a GBX 4,900 ($63.37) price target on shares of Shire PLC in a research note on Tuesday, July 18th. Four analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of GBX 5,896.12 ($76.26).
In other news, insider Dominic Blakemore purchased 152 shares of Shire PLC stock in a transaction on Friday, June 30th. The stock was purchased at an average price of GBX 4,255 ($55.03) per share, with a total value of £6,467.60 ($8,364.72). Also, insider Flemming Ornskov purchased 8,400 shares of Shire PLC stock in a transaction on Tuesday, August 22nd. The shares were purchased at an average cost of GBX 3,665 ($47.40) per share, with a total value of £307,860 ($398,163.48).
Shire PLC Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.